DMD and neoplasm: To identify downstream molecular pathways that could be associated with such DMD downregulation (analogous to the impact of full-length dystrophin loss in muscle), we compared transcriptomes of primary tumor samples with low vs. high DMD gene expression from 15 different tumor types: BRCA, BLCA, UCEC, CESC, OV, COAD, STAD, PRAD, LUSC, ESCA, HNSC, LUAD, KIRP, and THCA, where Dp427m was found to be downregulated compared to control tissues.